ERBB2 and neoplasm: This indicates that mutant HER3 may not be able to induce oncogenic transformation alone but requires HER2 expression to enhance tumor growth, consistent with HER3 being highly kinase-impaired [127] (in the absence of mutations that alter its kinase activity).